
India's Apollo Hospitals beats estimates for Q1 profit on strong demand
The hospital chain operator reported a consolidated net profit that rose 41.8% to 4.33 billion rupees ($49.40 million)for the April-June quarter.
Analysts, on average, had expected of 3.86 billion rupees, according to data compiled by LSEG.
Indian hospital chains such as Apollo and Manipal have been increasing their bed count for a larger share of the market, including through acquisitions of smaller hospital operators. Temasek-backed Manipal acquired a majority stake in local peer Sahyadri Hospitals last month.
Apollo said it is on track to add 4,370 beds over the next 3-4 years through acquisition, setting up new hospitals, as well as expansion of existing facilities. The hospital operator had 8,030 operational beds as of June 30.
Occupancy rate for the quarter, however, saw a slight dip to 65% from 68% last year.
Total revenue for the first quarter rose 15% to 58.42 billion rupees beating estimates of 57.44 billion rupees, aided by a 12% growth in the healthcare services business that contributes more than half of the total revenue.
The company expects double-digit revenue growth for the current financial year.
Its offline pharmacy and digital healthcare business reported a 19% rise in revenue. Apollo spun off the business recently and aims to list it as a separate entity in the next 18-21 months.
($1 = 87.6520 Indian rupees)
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Reuters
12 minutes ago
- Reuters
Texas sues Eli Lilly for allegedly bribing providers to prescribe its medications
WASHINGTON, Aug 12 (Reuters) - Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly (LLY.N), opens new tab for allegedly "bribing" providers to prescribe its medications. The attorney general's office said in a statement the company bribed and illegally induced medical providers to prescribe its most profitable drugs, including the GLP-1 medications Mounjaro and Zepbound that are used for weight loss and diabetes treatment.


Reuters
an hour ago
- Reuters
India's Apollo Hospitals to double AI investments, beats profit estimate
HYDERABAD, Aug 12 (Reuters) - India's Apollo Hospitals Enterprise ( opens new tab plans to double its investment in artificial intelligence capabilities over the next two to three years, its CEO said, after the company beat first-quarter profit estimates on higher patient volume. The hospital chain already uses AI tools in diagnosis to read X-rays, scan reports and also in endoscopy - a medical procedure to examine the inside of the body using a camera, CEO Madhu Sasidhar told Reuters on Tuesday. Many large private hospital chains in India, like their western counterparts, are investing in AI capabilities to improve patient diagnosis and decisions related to medical procedures, among others uses. Apollo recently developed technology to read existing scan reports and predict the risk of liver fibrosis in the future, Sasidhar said. "We are also bringing some other new generation agentic AI-type tools," he said. He did not quantify the size of Apollo's existing investment in AI. Apollo, headquartered in the south Indian city of Chennai, partnered with Microsoft (MSFT.O), opens new tab earlier this year to develop AI-based tools to be used in healthcare. Some of them are in early stages of testing, Sasidhar said. Indian hospital chains such as Apollo and Manipal have also been increasing their bed count for a larger share of the market, including through acquisitions of smaller hospital operators. Apollo said it is on track to add 4,370 beds over the next 3-4 years through acquisition, new hospitals and expansion of existing facilities. Its overall bed capacity is currently more than 10,000. The company's consolidated net profit rose 41.8% to 4.33 billion rupees ($49.40 million) for April-June, beating estimates of 3.86 billion rupees, according to data compiled by LSEG. While its overall occupancy rate dipped from last year, in-patient volume grew 3% and average revenue per in-patient increased by 9%, according to Apollo. Quarterly total revenue rose 15% to 58.42 billion rupees, beating estimates of 57.44 billion rupees. The company said it expects double-digit revenue growth for the current financial year. ($1 = 87.6520 Indian rupees)


The Guardian
an hour ago
- The Guardian
A China-led global system alongside that of the US is Xi Jinping's ultimate aim
I enjoyed reading George Magnus's article (Why Peak China may finally have arrived, 11 August). However, focusing on peak economic growth misses the bigger picture and underestimates China in ways that could weaken western policy responses. China's central goal is national power, and we are far from its peak national power. The Chinese economic miracle has taken place under the US-led global system. China built factories along its coast, filled container ships, and sent its goods to developed markets, effectively plugging into an existing network of shipping routes, ports and railways. However, just as easily as China joined this system, so too can it be forcefully unplugged. This is a core national security concern and, for more than a decade, China has been building an alternative to this US-led order. The belt and road initiative has created new trading networks across the global south; the Cross-Border Interbank Payment System (Cips) allows China and its partners to move money beyond the gaze of the US government; the 'Made in China 2025' policy has established China as a global leader in science and technology; and the modernisation of its military will allow China to project power beyond its borders. On his first and only visit to the US since the pandemic, Xi Jinping declared to Joe Biden that 'Planet Earth is big enough for the two countries to succeed'. Policymakers should understand this as a statement of intent. Even with slower growth, the party commands enough of the nation's wealth and resources to pursue its ultimate aim: a parallel, China-led global J SinclairVisiting assistant professor of finance, California Institute of Technology Have an opinion on anything you've read in the Guardian today? Please email us your letter and it will be considered for publication in our letters section.